Immune activation is essential for the antitumor activity of EZH2 inhibition in urothelial carcinoma.
Piunti A, Meghani K, Yu Y, Robertson AG, Podojil JR, McLaughlin KA, You Z, Fantini D, Chiang M, Luo Y, Wang L, Heyen N, Qian J, Miller SD, Shilatifard A, Meeks JJ.
Piunti A, et al. Among authors: meghani k.
Sci Adv. 2022 Oct 7;8(40):eabo8043. doi: 10.1126/sciadv.abo8043. Epub 2022 Oct 5.
Sci Adv. 2022.
PMID: 36197969
Free PMC article.